Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$605M |
| 2 |
American Tower
AMT
|
+$352M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$347M |
| 4 |
TJX Companies
TJX
|
+$309M |
| 5 |
ExxonMobil
XOM
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$924M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$617M |
| 3 |
United Parcel Service
UPS
|
+$546M |
| 4 |
Qualcomm
QCOM
|
+$540M |
| 5 |
Eaton
ETN
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.22% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.58% |
| 4 | Industrials | 8.26% |
| 5 | Consumer Discretionary | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Ardelyx
ARDX
$997M
| $103K | ﹤0.01% |
+13,933
| New | +$98K |
|
3702
InfuSystem Holdings
INFU
$241M
| $103K | ﹤0.01% |
+15,085
| New | +$111K |
|
|
TBNK
3703
DELISTED
Territorial Bancorp Inc.
TBNK
| $103K | ﹤0.01% |
12,700
-379,020
| -97% | -$2.95M |
|
3704
Cogent Biosciences
COGT
$7.1B
| $101K | ﹤0.01% |
+12,005
| New | +$91.1K |
|
3705
Nuveen Municipal Income
NMI
$130M
| $101K | ﹤0.01% |
10,301
| – | – |
|
3706
Granite Ridge Resources
GRNT
$670M
| $100K | ﹤0.01% |
+15,847
| New | +$102K |
|
3707
Ambev
ABEV
$45.4B
| $99.8K | ﹤0.01% |
48,663
+18,064
| +59% | +$41.1K |
|
3708
Biote Corp
BTMD
$46.7M
| $98.9K | ﹤0.01% |
+13,233
| New | +$81.6K |
|
3709
Korea Electric Power
KEP
$15.7B
| $97.5K | ﹤0.01% |
13,755
-4,628
| -25% | -$34.8K |
|
3710
1stdibs.com
DIBS
$153M
| $91.7K | ﹤0.01% |
20,423
| – | – |
|
|
MRSN
3711
DELISTED
Mersana Therapeutics
MRSN
| $91.5K | ﹤0.01% |
1,822
+1,106
| +154% | +$80K |
|
|
AHT
3712
Ashford Hospitality Trust
AHT
$20.7M
| $90.7K | ﹤0.01% |
9,338
-20,571
| -69% | -$247K |
|
|
FSCO
3713
FS Credit Opportunities Corp
FSCO
$1.01B
| $90.4K | ﹤0.01% |
14,196
-9,752
| -41% | -$59.9K |
|
3714
UNIFI
UFI
$129M
| $89.3K | ﹤0.01% |
15,167
-7,477
| -33% | -$44.5K |
|
3715
Community Health Systems
CYH
$415M
| $89K | ﹤0.01% |
26,481
-5,197
| -16% | -$17.5K |
|
3716
Agilon Health
AGL
$1.63B
| $83.6K | ﹤0.01% |
+512
| New | +$72.9K |
|
3717
Aemetis
AMTX
$120M
| $83.4K | ﹤0.01% |
27,700
-4,100
| -13% | -$15.6K |
|
3718
CEMIG Preferred Shares
CIG
$5.84B
| $81.5K | ﹤0.01% |
46,218
-4
| -0% | -$8 |
|
3719
PMV Pharmaceuticals
PMVP
$65.6M
| $80.7K | ﹤0.01% |
49,794
| – | – |
|
|
GTHX
3720
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $79.6K | ﹤0.01% |
34,900
-600
| -2% | -$2.29K |
|
3721
UWM Holdings
UWMC
$2.26B
| $79.1K | ﹤0.01% |
11,332
-61,533
| -84% | -$423K |
|
3722
Kodiak Sciences
KOD
$2.72B
| $79K | ﹤0.01% |
33,628
-11,635
| -26% | -$39.4K |
|
|
PGRE
3723
DELISTED
Paramount Group
PGRE
| $76.3K | ﹤0.01% |
16,356
-67,119
| -80% | -$311K |
|
3724
Gerdau
GGB
$9.74B
| $75.6K | ﹤0.01% |
22,923
+7,483
| +48% | +$26.4K |
|
3725
Bausch Health
BHC
$2.37B
| $75.6K | ﹤0.01% |
10,852
-65,736
| -86% | -$497K |
|
Similar funds
Ameriprise's Q2 2024 Portfolio in Review
As of Q2 2024, Ameriprise held 3,986 positions worth $370B, up 1.7% from $363B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Ameriprise's Q2 2024 filing shows 147 new, 1,504 increased, 2,054 reduced and 132 closed positions. Its largest new stake was GE Vernova: 483,715 shares worth $83M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $924M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2024 buy was GE Vernova: 483,715 shares worth $83M.
- Ameriprise added most to Apple in Q2 2024, an estimated $605M increase.
- Ameriprise's biggest Q2 2024 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $924M.
- Ameriprise fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $313M.
- Ameriprise's ten largest holdings make up 20% of its $370B portfolio in Q2 2024.
- Ameriprise opened 147 new positions and closed 132 in Q2 2024.
- Ameriprise's portfolio value rose 1.7% quarter-over-quarter to $370B.
Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.